Gynazole 1 Cream
Pricing Report NDC 45802-396-01
View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Current Package Pricing Information
The current wholesale acquisition cost for Gynazole 1 (NDC 45802-396-01) is $23.35167 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jun 17, 2026.
As a a human prescription drug provided by Padagis Israel Pharmaceuticals Ltd, this medication is distributed in a 1 TUBE, WITH APPLICATOR in 1 CARTON / 5.8 g in 1 TUBE, WITH APPLICATOR configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.
NADAC Pricing Summary
NADAC pricing snapshot for this package NDC
Acquisition Cost $23.35167 Per GM
Pricing Unit
Effective Date
Jun 17, 2026
Billable Units
5.8 GM
Estimated Package Price
$135.44
Data Status
As of Jul 08, 2026
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
Historical Pricing Trends & Acquisition Cost Benchmarks
Since Aug 2015, the NADAC wholesale price for (NDC ) has moved within a range of $13.25000 to $23.54880 per GM. Over this 10 years and 9 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.
Price Range
$13.2500 - $23.5488
$13.2500 - $23.5488
Market Volatility
77.73% Variance
77.73% Variance
Latest Trend
No Change
No Change
| Date | Unit Price | Unit | Source | Method | Rate |
|---|---|---|---|---|---|
| Jun 17, 2026 | $23.35167 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| May 20, 2026 | $23.35167 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Apr 22, 2026 | $23.39413 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Mar 18, 2026 | $23.35250 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Feb 18, 2026 | $23.41215 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 21, 2026 | $23.41215 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Dec 17, 2025 | $23.38083 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Nov 19, 2025 | $23.38083 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Oct 22, 2025 | $23.43900 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Sep 17, 2025 | $23.54880 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Aug 20, 2025 | $23.51729 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Jul 23, 2025 | $23.51729 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Jun 18, 2025 | $23.42846 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| May 21, 2025 | $23.35600 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Apr 23, 2025 | $23.35600 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Mar 19, 2025 | $23.31538 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Feb 19, 2025 | $23.34914 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 22, 2025 | $23.34914 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Dec 18, 2024 | $23.27907 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Nov 20, 2024 | $23.27907 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Oct 23, 2024 | $23.23308 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Sep 18, 2024 | $23.23308 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Aug 21, 2024 | $23.23073 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Jul 17, 2024 | $23.23073 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Jun 19, 2024 | $23.32140 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| May 22, 2024 | $23.37422 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Apr 17, 2024 | $23.26660 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Jul 21, 2021 | $21.07840 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Jul 21, 2021 | $21.07840 | GM | C/I - Chain or Independent Pharmacy | Code 4, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Aug 05, 2020 | $20.71080 | GM | C/I - Chain or Independent Pharmacy | Code 2, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Aug 05, 2020 | $20.71080 | GM | C/I - Chain or Independent Pharmacy | Code 3, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Aug 05, 2020 | $20.71080 | GM | C/I - Chain or Independent Pharmacy | Code 4, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Jul 22, 2020 | $19.91500 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Apr 17, 2019 | $20.44160 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Apr 17, 2019 | $20.44160 | GM | C/I - Chain or Independent Pharmacy | Code 2, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Apr 17, 2019 | $20.44160 | GM | C/I - Chain or Independent Pharmacy | Code 4, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| May 15, 2018 | $20.03640 | GM | C/I - Chain or Independent Pharmacy | Code 2, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| May 15, 2018 | $20.03640 | GM | C/I - Chain or Independent Pharmacy | Code 3, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| May 15, 2018 | $20.03640 | GM | C/I - Chain or Independent Pharmacy | Code 4, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Sep 27, 2017 | $19.08174 | GM | C/I - Chain or Independent Pharmacy | Code 2, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Sep 27, 2017 | $19.08174 | GM | C/I - Chain or Independent Pharmacy | Code 3, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Sep 27, 2017 | $19.08174 | GM | C/I - Chain or Independent Pharmacy | Code 4, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Jul 19, 2017 | $18.17343 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Jul 19, 2017 | $18.17343 | GM | C/I - Chain or Independent Pharmacy | Code 4, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Sep 21, 2016 | $18.64077 | GM | C/I - Chain or Independent Pharmacy | Code 2, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Sep 21, 2016 | $18.64077 | GM | C/I - Chain or Independent Pharmacy | Code 3, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Sep 21, 2016 | $18.64077 | GM | C/I - Chain or Independent Pharmacy | Code 4, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Aug 26, 2016 | $18.23610 | GM | C/I - Chain or Independent Pharmacy | Code 3, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| May 18, 2016 | $16.72975 | GM | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| May 18, 2016 | $16.72975 | GM | C/I - Chain or Independent Pharmacy | Code 4, 5, 6 | B-ANDA - Abbreviated New Drug Application |
| Aug 19, 2015 | $13.25000 | GM | C/I - Chain or Independent Pharmacy | Code 4, 5, 6 | B-ANDA - Abbreviated New Drug Application |
Pricing Methodology Legend
- Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
- Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
- Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
- Code 4: The NADAC was carried forward from the previous file.
- Code 5: The NADAC was calculated based on package size.
- Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
Understanding NADAC Pricing Data
The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.
Important Price Distinction:
The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.
NADAC Pricing Data Last Updated on: July 08, 2026
